BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7385715)

  • 1. [Breast cancer in the Estonian SSR: incidence and survival rate].
    Khint EK
    Vopr Onkol; 1980; 26(5):68-71. PubMed ID: 7385715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age distribution of breast cancer in Lebanon: increased percentages and age adjusted incidence rates of younger-aged groups at presentation.
    El Saghir NS; Shamseddine AI; Geara F; Bikhazi K; Rahal B; Salem ZM; Taher A; Tawil A; El Khatib Z; Abbas J; Hourani M; Seoud M
    J Med Liban; 2002; 50(1-2):3-9. PubMed ID: 12841305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival patterns of female breast cancer patients in the Estonian SSR in 1968-1981.
    Aaredeid T
    Neoplasma; 1985; 32(2):257-63. PubMed ID: 4000313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the background of differences in survival of female breast cancer patients in the German Democratic Republic and the Estonian SSR.
    Aareleid T; Staneczek W; Rahu M; Möhner M
    Neoplasma; 1990; 37(5):587-94. PubMed ID: 2234218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the incidence and survival of female breast cancer in Beijing during the last 20 years].
    Wang QJ; Zhu WX; Xing XM
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):208-10. PubMed ID: 16875607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence statistics of malignant stomach neoplasms in the Estonian SSR during 1963-1972].
    Rakhu MA
    Vopr Onkol; 1977; 23(5):41-5. PubMed ID: 888416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calculation of survival rates of patients with breast cancer in the Estonian SSR, 1968-1981].
    Aareleĭd TP
    Vopr Onkol; 1986; 32(12):8-12. PubMed ID: 3798843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of epidemiologic features of female breast cancer in the German Democratic Republic and the Estonian SSR, 1968-1980.
    Aareleid T; Staneczek W; Haas J; Rahu M
    Arch Geschwulstforsch; 1985; 55(2):139-46. PubMed ID: 4004509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer trends in Manitoba: 40 years of follow-up.
    Demers AA; Turner D; Mo D; Kliewer EV
    Chronic Dis Can; 2005; 26(1):13-9. PubMed ID: 16117841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].
    Liao ML; Chen ZW; Zheng Y; Wu CX; Lu S; Yu YF; Jian H; Cheng BJ
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1876-80. PubMed ID: 17923007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008].
    Yang L; Sun TT; Wang N
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Nov; 46(11):1009-14. PubMed ID: 23363922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology of breast cancer in Austria (author's transl)].
    Kucera H; Michalica W
    Wien Med Wochenschr; 1979 Dec; 199(24):703-6. PubMed ID: 547497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Time trends, estimates and projects for breast cancer incidence and mortality in China].
    Yang L; Li LD; Chen YD; Parkin DM
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):438-40. PubMed ID: 17152490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands.
    Louwman WJ; Voogd AC; van Dijck JA; Nieuwenhuijzen GA; Ribot J; Pruijt JF; Coebergh JW
    Cancer Causes Control; 2008 Feb; 19(1):97-106. PubMed ID: 18038250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The risk of breast cancer in Catalonia].
    Izquierdo A; Viladiu P; Borrás J; Galcerán J; Borràs JM; Dorca J; Vayreda J; Moreno V
    Med Clin (Barc); 1996 Oct; 107(11):410-3. PubMed ID: 9045002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The evolution and prediction of the incidence of breast cancer in Zaragoza, 1961-2000].
    Vioque J; Navarro Gracia JF; Millas Ros J; Mateo de las Heras E
    Med Clin (Barc); 1993 May; 101(1):12-7. PubMed ID: 8315970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.